Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Merck presents amine derivatives with PDE5-inhibitory effects

May 21, 2001

Preparation and therapeutic uses of new alpha1A-adrenoceptor antagonists disclosed by Synaptic

May 18, 2001

EMD-221963, a representative NHE-3 inhibitor from Merck KGaA

May 17, 2001

NDA filed in Hong Kong for NexMed's ED treatment

May 16, 2001

Tanabe Seiyaku issued patent covering new PDE5 inhibitors and their use

May 11, 2001

Watson seeks FDA approval for overactive bladder treatment

May 4, 2001

Kissei and Daiichi will codevelop and comarket BPH Rx in Japan

May 3, 2001

Cialis demonstrates extended duration in clinical trials in ED

May 3, 2001

Tolterodine ER shows improved efficacy and safety

May 2, 2001

Senetek's Invicorp well tolerated for ED in hypertensive patients

April 25, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...